ATAD3B

Chr 1

ATPase family AAA domain containing 3B

Also known as: AAA-TOB3, TOB3

The protein encoded by this gene is localized to the mitochondrial inner membrane, where it can bind to a highly-related protein, ATAD3A. ATAD3A appears to interact with matrix nucleoid complexes, and the encoded protein negatively regulates that interaction. This gene is expressed almost exclusively in pluripotent embryonic stem cells and some cancer cells. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 1.48
Clinical SummaryATAD3B
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 193 VUS of 258 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.48LOEUF
pLI 0.000
Z-score -0.50
OE 1.10 (0.831.48)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-2.79Z-score
OE missense 1.39 (1.301.49)
557 obs / 399.9 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.10 (0.831.48)
00.351.4
Missense OE?1.39 (1.301.49)
00.61.4
Synonymous OE?1.33
01.21.6
LoF obs/exp: 32 / 29.1Missense obs/exp: 557 / 399.9Syn Z: -3.46

This gene — mechanism propensity

DN
0.74top 25%
GOF
0.76top 25%
LOF
0.3357th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

258 submitted variants in ClinVar

Classification Summary

Pathogenic6
VUS193
Likely Benign18
Benign6
Conflicting2
6
Pathogenic
193
VUS
18
Likely Benign
6
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
6
0
6
Likely Pathogenic
0
0
0
0
0
VUS
2
187
4
0
193
Likely Benign
0
14
1
3
18
Benign
0
3
2
1
6
Conflicting
2
Total2204134225

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

137 pathogenic / likely-pathogenic (of 174) ClinVar copy-number / structural variants overlap ATAD3B — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ATAD3B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →